Stocks and Investing
Stocks and Investing
Tue, July 9, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, July 8, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Derek Archila Upgraded (SLRN) to Buy and Held Target at $13 on, Jul 8th, 2024
Derek Archila of Wells Fargo, Upgraded "Acelyrin, Inc." (SLRN) to Buy and Held Target at $13 on, Jul 8th, 2024.
Derek has made no other calls on SLRN in the last 4 months.
There is 1 other peer that has a rating on SLRN. Out of the 1 peers that are also analyzing SLRN, 0 agree with Derek's Rating of Hold.
This is the rating of the analyst that currently disagrees with Derek
- Emily Bodnar of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $18 on, Wednesday, May 22nd, 2024
Contributing Sources